Phenylketonuria (PKU), an inherited metabolic disorder affecting approximately 1 in 10,000 to 1 in 15,000 individuals globally [1], is characterized by the deficiency in phenylalanine hydroxylase (PAH) enzyme, which is pivotal for the metabolism of amino acid phenylalanine. Here, PAH is linked to Other metabolic disease.